Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
August 31, 2022
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials
Jesse G Dixon, Çağlar Çağlayan, Dai Chihara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2012
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era
Silvia Montoto, Kate Shaw, Jessica Okosun, et al.
The New England Journal of Medicine
|
October 5, 2017
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Robert Marcus, Andrew Davies, Kiyoshi Ando, et al.
Pediatric Blood & Cancer
|
December 30, 2017
Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study
Julio C Barredo, Caroline Hastings, Xiamin Lu, et al.
Blood
|
October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
Carla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Magdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, et al.
Blood Advances
|
March 22, 2021
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials
Carla Casulo, Jesse G Dixon, Fang-Shu Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2023
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study
Christiane Pott, Vindi Jurinovic, Judith Trotman, et al.
Hemasphere
|
July 5, 2023
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study
William Townsend, Wolfgang Hiddemann, Christian Buske, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials
Qian Shi, Christopher R Flowers, Wolfgang Hiddemann, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Clinical Lymphoma, Myeloma & Leukemia
|
August 31, 2022
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials
Jesse G Dixon, Çağlar Çağlayan, Dai Chihara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 10, 2012
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era
Silvia Montoto, Kate Shaw, Jessica Okosun, et al.
The New England Journal of Medicine
|
October 5, 2017
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Robert Marcus, Andrew Davies, Kiyoshi Ando, et al.
Pediatric Blood & Cancer
|
December 30, 2017
Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study
Julio C Barredo, Caroline Hastings, Xiamin Lu, et al.
Blood
|
October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
Carla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2019
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Magdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, et al.
Blood Advances
|
March 22, 2021
Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials
Carla Casulo, Jesse G Dixon, Fang-Shu Ou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2023
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study
Christiane Pott, Vindi Jurinovic, Judith Trotman, et al.
Hemasphere
|
July 5, 2023
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study
William Townsend, Wolfgang Hiddemann, Christian Buske, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2016
Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials
Qian Shi, Christopher R Flowers, Wolfgang Hiddemann, et al.
Page
of 10